ARBUTUS BIOPHARMA CORP (ABUS) Institutional Ownership and Insiders Activity

ARBUTUS BIOPHARMA CORP (ABUS) is widely held by institutional investors, with 177 firms reporting positions valued at approximately $624.34M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Morgan Stanley is the largest disclosed holder, reporting approximately $84.95M in ABUS holdings in its latest filing.

Recent insider activity includes 16 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.